Company Biotest Med Srl with Fiscal Code 14737577
recorded a turnover of 2024 of
1.461.994,
with a net profit of
234.524
and having an average number of employees of
21.
The company operates in the field of Servicii de diagnostic imagistic și activități ale laboratoarelor medicale having the NACE code 8691.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Biotest Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
333.864
500.758
719.451
910.510
870.391
727.574
887.035
1.077.427
1.427.061
1.461.994
Total Income - EUR
334.042
500.760
720.399
910.580
870.395
730.451
887.146
1.077.958
1.429.149
1.471.043
Total Expenses - EUR
376.184
467.887
527.878
603.098
650.468
558.266
654.551
812.016
1.193.878
1.188.417
Gross Profit/Loss - EUR
-42.142
32.873
192.521
307.482
219.927
172.185
232.595
265.943
235.272
282.625
Net Profit/Loss - EUR
-42.142
25.799
167.578
298.377
211.223
165.232
223.724
255.650
200.947
234.524
Employees
13
12
13
0
15
13
16
15
21
21
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 3.0%, from 1.427.061 euro in the year 2023, to 1.461.994 euro in 2024.
The Net Profit increased by 34.700 euro, from 200.947 euro in 2023, to 234.524 in the last year.
Check the financial reports for the company - Biotest Med Srl
Financial Rating - BIOTEST MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Biotest Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Biotest Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Biotest Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Biotest Med Srl - CUI 14737577
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
62.558
110.455
82.813
62.458
62.546
58.733
51.733
83.297
72.390
85.858
Current Assets
103.767
183.410
463.227
808.918
879.803
1.071.019
1.206.495
1.609.358
2.051.370
2.378.366
Inventories
25.402
37.011
44.015
44.522
41.539
27.097
26.721
56.660
85.539
127.507
Receivables
75.106
138.905
407.072
751.778
798.307
995.172
1.005.891
1.304.207
1.876.802
2.197.098
Cash
3.259
7.494
12.139
12.618
39.956
48.750
173.884
248.491
89.029
53.760
Shareholders Funds
-79.276
-52.668
115.801
412.054
615.297
768.865
975.539
1.234.215
1.431.420
1.456.911
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
245.333
346.533
429.979
459.067
326.802
360.641
282.449
463.878
692.818
1.010.715
Income in Advance
267
265
260
256
251
246
240
241
240
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8691 - 8691"
CAEN Financial Year
8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
2.378.366 euro in 2024 which includes Inventories of
127.507 euro, Receivables of
2.197.098 euro and cash availability of
53.760 euro.
The company's Equity was valued at
1.456.911 euro, while total Liabilities amounted to
1.010.715 euro.
Equity increased by 33.491 euro, from 1.431.420 euro in 2023, to 1.456.911 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Biotest Med Srl